POET is trading at $22.74 (+10.5%) after hours after the company announced a $50 million supply and joint development agreement with Lumilens Inc. for AI data center solutions.
- The agreement includes an initial purchase order with the potential to scale to $500 million as the partnership develops.
- The stock is extending its regular-session momentum, with the Lumilens deal serving as the primary catalyst for the move.
- While broader market sentiment remains firm, the company-specific development is the clear driver of the double-digit gains.